Combination of oxaliplatin (OXA) and 5-fluorouracil, leucovorin (5-FU/LV), as first line therapy, in elderly patients >70years, with metastatic colorectal cancer.

被引：0
|
作者：
Botto, HG [1 ]
机构：
[1] FOI, Buenos Aires, DF, Argentina
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3717
引用
收藏
页码：298S / 298S
页数：1
相关论文
共 50 条
  • [1] Oxaliplatin (OXA), 5-fluorouracil (5-FU) and leucovorin (LV) in patients with advanced or metastatic gastric cancer (A/MGC).
    Cavanna, L
    Zaniboni, A
    Artioli, F
    Lazzaro, A
    Rizzi, A
    Mazzocchi, M
    Bernuzzi, P
    Bertè, R
    Bidin, L
    Palladino, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 330S - 330S
  • [2] Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic gastric cancer (MGC)
    Cavanna, Luigi
    Artioli, Fabrizio
    Codignola, Claudio
    Lazzaro, Antonio
    Rizzi, Anna
    Gamboni, Alessandro
    Rota, Luigina
    Rodino, Carmelina
    Boni, Fabrizio
    Iop, Aldo
    Zaniboni, Alberto
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (04): : 371 - 375
  • [3] Third line oxaliplatin with leucovorin (LV) and continuous infusion 5-fluorouracil (5FU) in metastatic colorectal cancer.
    Abón, G
    Muñoz, A
    Rubio, I
    Mañé, JM
    Ferreiro, J
    Fernández, R
    Fuente, N
    López-Argumedo, G
    Barceló, R
    Vivanco, GL
    ANNALS OF ONCOLOGY, 2000, 11 : 48 - 49
  • [4] Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in previously treated patients with advanced metastatic gastric cancer
    Cavanna, L
    Zaniboni, A
    Artioli, F
    Lazzaro, A
    Rizzi, A
    Mazzocchi, M
    Anselmi, E
    Bidin, L
    Palladino, M
    Rodinò, C
    ANNALS OF ONCOLOGY, 2005, 16 : 323 - 323
  • [5] Suramin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in metastatic colorectal cancer patients resistant to 5-FU+LV-based chemotherapy
    Falcone, A
    Pfanner, E
    Brunetti, I
    Allegrini, G
    Lencioni, M
    Galli, C
    Masi, G
    Danesi, D
    Antonuzzo, A
    Del Tacca, M
    Conte, PF
    TUMORI, 1998, 84 (06) : 666 - 668
  • [6] First-line chemotherapy with low-dose leucovorin plus 5-fluorouracil (LV/5-FU) for elderly patients with metastatic colorectal cancer
    Yoshimatsu, Kazuhiko
    Yokomizo, Hajime
    Fujimoto, Takashi
    Umehara, Arihiro
    Otani, Taisuke
    Matsumoto, Atsuo
    Osawa, Gakuji
    Shiozawa, Shunichi
    Katsube, Takao
    Naritaka, Yoshihiko
    Ogawa, Kenji
    ANTICANCER RESEARCH, 2007, 27 (3B) : 1641 - 1644
  • [7] Phase I trial of ZD1839 ('Iressa') in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic colorectal cancer.
    de Bono, JS
    Hammond, LA
    Figueroa, J
    Schwartzberg, L
    Ochoa, L
    Patnaik, A
    Olivo, N
    Schwartz, G
    Smith, L
    Ochs, J
    Rowinsky, EK
    BRITISH JOURNAL OF CANCER, 2002, 86 : S50 - S51
  • [8] Oxaliplatin in combination with 5-fluorouracil/leucovorin or capecitabine in elderly patients with metastatic colorectal cancer
    Arkenau, Hendrik-Tobias
    Graeven, Ullrich
    Kubicka, Stephan
    Grothey, Axel
    Englisch-Fritz, Christina
    Kretzschmar, Albrecht
    Greil, Richard
    Freier, Werner
    Seufferlein, Thomas
    Hinke, Axel
    Schmoll, Hans-Joachim
    Schmiegel, Wolff
    Porschen, Rainer
    CLINICAL COLORECTAL CANCER, 2008, 7 (01) : 60 - 64
  • [9] 5-FLUOROURACIL (5-FU) COMBINED WITH LEUCOVORIN (LV) IN PATIENTS WITH ADVANCED 5-FU RESISTANT COLORECTAL-CANCER
    VANGROENINGEN, CJ
    PETERS, GJ
    PINEDO, HM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 202 - 202
  • [10] Oxaliplatin/5-FU chemotherapy without leucovorin in metastatic colorectal cancer.
    Shim, BY
    Cho, HJ
    Yang, JM
    Kim, HJ
    Kim, JK
    Kim, HK
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 302S - 302S
12345